Your Search for 'OTC Pharmaceuticals - Colombia - a snapshot (2011)' returned 12 results - Page 1 of 1

• The Pharmaceutical Market: Peru

  EURO€ 985.00USD$ 1,281.00GBP£ 829.00AUD$ 1,253.00JPY¥ 126,522.00SEK 8 414,00CHF 1'208.00CAD$ 1,306.00 Espicom Business Intelligence Ltd, May 2012 , Pages: 58
  in Bolivia, Colombia, Ecuador and Venezuela. The company has six divisions. In February 2011, Química Suiza acquired the pharmacy chain Boticas BTL for an undisclosed transaction value. With this ...

• Colombia Pharmaceuticals and Healthcare Report Q3 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Jun 2011 , Pages: 94
  Colombia Pharmaceuticals and Healthcare Report Q3 2011 The Colombia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical ...

• Pharmaceuticals - Global Outlook

  EURO€ 1,766.00USD$ 1,995.00GBP£ 1,177.00AUD$ 2,759.00JPY¥ 239,238.00SEK 15 694,00CHF 2'627.00CAD$ 2,559.00 Global Industry Analysts, Inc, Jan 2012 , Pages: 443
  for Prescription Pharmaceuticals by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2011 and ...

• Colombia Pharmaceuticals and Healthcare Report Q2 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Mar 2012 , Pages: 94
  Colombia Pharmaceuticals and Healthcare Report Q2 2012 Business Monitor International's Colombia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate ...

• Colombia Retail Report Q4 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Sep 2011 , Pages: 62
  -counter (OTC) pharmaceuticals are forecast to grow from US$0.58bn in 2011 to US$1.21bn by 2015, a rise of 108%. Sales of consumer electronic products are forecast at US$4.21bn in 2011, with BMI predicting ...

• Peru Pharmaceuticals and Healthcare Report Q4 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Sep 2011 , Pages: 86
  Peru Pharmaceuticals and Healthcare Report Q4 2011 BMI View: From a number of viewpoints, Peru offers considerable rewards to pharmaceutical and healthcare industry players, not least due to its fast ...

• Venezuela Pharmaceuticals and Healthcare Report Q2 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Apr 2012 , Pages: 93
  . Headline Expenditure Projections - Pharmaceuticals: VEF33.26bn (US$5.45bn) in 2011 to VEF41.16bn (US$6.05bn) in 2012; +23.8% in local currency terms and +11% in US dollar terms. US forecast up due to new ...

• Puerto Rico Pharmaceuticals and Healthcare Report Q1 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Dec 2011 , Pages: 83
  closely tied with the state of its economy, which is already struggling against headwinds from the US Headline Expenditure Projections - Pharmaceuticals: US$2.75bn in 2010 to US$2.81bn in 2011; +2.0% in ...

• Vietnam Pharmaceuticals and Healthcare Report Q1 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Jan 2012 , Pages: 101
  - Pharmaceuticals: VND32,773bn (US$1.71bn) in 2010 to VND38,902bn (US$1.89bn) in 2011; +18.5% in local currency terms and +10.3% in US dollar terms. Forecast largely unchanged from Q411 due to elevated inflation ...

• Venezuela Pharmaceuticals and Healthcare Report Q4 2010

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Oct 2010 , Pages: 83
  Venezuela Pharmaceuticals and Healthcare Report Q4 2010 The authors forecast a 3.8% year-on-year (y-o-y) contraction in Venezuelan real GDP for 2010, however, contrary to consensus the authors ...

• Colombia Retail Report Q2 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Mar 2011 , Pages: 53
  comprehensive health insurance plans, sales of over the counter (OTC) pharmaceuticals are forecast to grow from US$0.59bn in 2011 to US$1.19bn by 2015, a rise of 102.5%. Sales of consumer electronic products are ...

• Argentina Pharmaceuticals and Healthcare Report Q2 2009

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Apr 2009 , Pages: 91
  Argentina Pharmaceuticals and Healthcare Report Q2 2009 The Argentina Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Argentina's pharmaceuticals ...